Clinical Trial Update: Radioligand fOr locAl raDiorecurrent proStaTe cancER [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of Phase 1 and Phase 2 trials evaluating a radioligand therapy for locally radiorecurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Glenn Bauman | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED